Conclusions  These results suggest that buprenorphine and buprenorphine/naloxone have similar abuse potential in non-dependent opioid abusers,
and that the addition of naloxone at these doses and in this dose ratio confers no evident advantage for decreasing the abuse
potential of intramuscular or sublingual buprenorphine in this population.

Content Type Journal ArticleCategory Original InvestigationDOI 10.1007/s00213-010-1898-4Authors
Angela N. Duke, The Johns Hopkins University School of Medicine Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences 5510 Nathan Shock Drive Baltimore MD 21224 USAChristopher J. Correia, The Johns Hopkins University School of Medicine Behavioral Pharmacology Research Unit, Department of Psychiatry and…